These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS. Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431 [TBL] [Abstract][Full Text] [Related]
11. Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome. Malin SK; Kirwan JP; Sia CL; González F J Clin Endocrinol Metab; 2014 Jan; 99(1):322-9. PubMed ID: 24203060 [TBL] [Abstract][Full Text] [Related]
12. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome. González F; Considine RV; Abdelhadi OA; Acton AJ J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727 [TBL] [Abstract][Full Text] [Related]
13. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. Mai K; Bobbert T; Reinecke F; Andres J; Maser-Gluth C; Wudy SA; Möhlig M; Weickert MO; Hartmann MF; Schulte HM; Diederich S; Pfeiffer AF; Spranger J J Clin Endocrinol Metab; 2008 Oct; 93(10):3900-6. PubMed ID: 18664538 [TBL] [Abstract][Full Text] [Related]
14. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome. Buyalos RP; Geffner ME; Azziz R; Judd HL Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990 [TBL] [Abstract][Full Text] [Related]
15. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes. Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477 [TBL] [Abstract][Full Text] [Related]
16. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome. Seow KM; Ting CH; Huang SW; Ho LT; Juan CC Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study. Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424 [TBL] [Abstract][Full Text] [Related]
18. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270 [TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. González F; Minium J; Rote NS; Kirwan JP J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479 [TBL] [Abstract][Full Text] [Related]
20. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]